View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest, Pf. 2, 1428
  • 2 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
Open access

Absztrakt:

A cukorbetegség és a depresszió világszerte népbetegség. Mindkettő kialakulása multifaktoriális, amelyben szerepet játszhatnak külső, környezeti tényezők, valamint belső, a szervezetben játszódó folyamatok, többek között különböző gének nem megfelelő működése. Bár a diabetes és a depresszió komorbiditása jól ismert, a két betegség hátterében zajló folyamatok, illetve ezen folyamatok egymásra hatása nem minden részletet illetően tisztázott. A szerzők összefoglaló közleményének célja bemutatni a 2-es típusú cukorbetegség és a depresszió közötti kétirányú kapcsolat hátterében álló ismert és még csak feltételezett mechanizmusokat, illetve felhívni a figyelmet a két betegség egyidejű szűrésének és kezelésének fontosságára, hiszen együttes fennállásukkor nőhet a morbiditás és a mortalitás. A cukorbetegek depresszióra irányuló szűrésével és a depressziós betegek diabetes irányú kivizsgálásával csökkenthető lehet a komorbiditásból származó komplikációk és szövődmények, illetve a kezelési nehézségek előfordulása. A két betegség ellátásában fontos szerepe van a családorvosnak, aki a korai diagnózissal és kezeléssel javíthatja a betegek életminőségét, lassíthatja a betegségek progresszióját és a szövődmények kialakulásának kockázatát. Orv Hetil. 2019; 160(21): 807–814.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    International Diabetes Federation. IDF Diabetes Atlas. Eight edition, 2017. Available from: http://www.diabetesatlas.org [accessed: December 10, 2018].

  • 2

    Jermendy G, Nádas J, Szigethy E, et al. Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20–69 years. Croat Med J. 2010; 51: 151–156.

  • 3

    Kempler P, Putz Zs, Kiss Z, et al. Prevalence and financial burden of type 2 diabetes mellitus in Hungary between 2001–2014 – results of the analysis of the National Health Insurance Fund database. [A 2-es típusú diabetes előfordulása és költségterheinek alakulása Magyarországon 2001–2014 között – az Országos Egészségbiztosítási Pénztár adatbázis-elemzésének eredményei.] Diab Hung. 2016; 24: 177–188. [Hungarian]

  • 4

    World Health Organization. Diabetes country profiles 2016. Hungary. WHO, Geneva. Available from: https://www.who.int/diabetes/country-profiles/hun_en.pdf?ua=1 [accessed: December 10, 2018].

  • 5

    Vámos EP, Kopp MS, Keszei A, et al. Prevalence of diabetes in a large, nationally representative population sample in Hungary. Diabetes Res Clin Pract. 2008; 81: e5–E8.

  • 6

    Domján BA, Ferencz V, Tänczer T, et al. Large increase in the prevalence of self-reported diabetes based on a nationally representative survey in Hungary. Prim Care Diabetes 2017; 11: 107–111.

  • 7

    World Health Organization. Depression and other common mental disorders. Global Health Estimates. WHO, Geneva, 2017. Available from: http://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/ [accessed: December 10, 2018].

  • 8

    World Federation for Mental Health. DEPRESSION: A global crisis. World Mental Health Day, October 10 2012. WHO, Geneva. Available from: http://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf [accessed: December 10, 2018].

  • 9

    Szádóczky E, Rihmer Z, Papp Z, et al. The prevalence of affective and anxiety disorders in primary care practice in Hungary. J Affect Disord. 1997; 43: 239–244.

  • 10

    Rihmer Z, Gonda X, Eőry A, et al. Screening of depression in primary care in Hungary and its importance in suicide prevention. [A depresszió szűrése az alapellátásban Magyarországon és ennek jelentősége az öngyilkosság megelőzésében.] Psychiatr Hung. 2012; 27: 224–232. [Hungarian]

  • 11

    Torzsa P, Rihmer Z, Gonda X, et al. Family history of suicide: a clinical marker for major depression in primary care practice? J Affect Disord. 2009; 117: 202–204.

  • 12

    Siu AL, US Preventive Services Task Force (USPSTF). Screening for depression in adults: US Preventive Services Task Force Recommendation Statement. JAMA 2016; 315: 380–387.

  • 13

    O’Connor E, Rossom RC, Henninger M, et al. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016; 315: 388–406.

  • 14

    Rihmer Z, Rutz W. Treatment of attempted suicide and suicidal patients in primary care. In: Wasserman D, Wasserman C. (eds.) Oxford Textbook of Suicidology and Suicide Prevention. Oxford University Press, Oxford, 2009; pp. 463–470.

  • 15

    Eurostat Statistics Explained. Causes of death – standardised death rate, 2015 (per 100 000 inhabitants) HLTH18.png. Eurostat, Luxembourg. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Causes_of_death_%E2%80%94_standardised_death_rate,_2015_(per_100_ 000_inhabitants)_HLTH18.png [accessed: December 10, 2018].

  • 16

    Torzsa P, Szeiffert L, Dunai K, et al. Diagnosis and therapy of depression in primary care. [A depresszió diagnosztikája és kezelése a családorvosi gyakorlatban.] Orv Hetil. 2009; 150: 1684–1693. [Hungarian]

  • 17

    Willis T. Diabetes: a medical Odyssey. USV Pharmaceutical Corp., Tuckahoe, NY, 1971.

  • 18

    Meurs M, Roest AM, Wolffenbuttel BH, et al. Association of depressive and anxiety disorders with diagnosed versus undiagnosed diabetes: An epidemiological study of 90,686 participants. Psychosom Med. 2016; 78: 233–241.

  • 19

    Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069–1078.

  • 20

    Ali S, Stone MA, Peters JL, et al. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006; 23: 1165–1173.

  • 21

    Kivimäki M, Tabák AG, Lawlor DB, et al. Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study. Diabetes Care 2010; 33: 1471–1476.

  • 22

    Rotella F, Mannucci E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract. 2013; 99: 98–104.

  • 23

    Eaton WW, Armenian H, Gallo J, et al. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19: 1097–1102.

  • 24

    Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383–2390.

  • 25

    Chen S, Zhang Q, Dai G, et al. Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis. Endocrine 2016; 53: 35–46.

  • 26

    Tabák AG, Akbaraly TN, Batty GD, et al. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol. 2014; 2: 236–245.

  • 27

    Scherrer JF, Xian H, Lustman PJ, et al. A test for common genetic and environmental vulnerability to depression and diabetes. Twin Res Hum Genet. 2011; 14: 169–172.

  • 28

    Mezuk B, Heh V, Prom-Wormley E, et al. Association between major depression and type 2 diabetes in midlife: findings from the Screening Across the Lifespan Twin Study. Psychosom Med. 2015; 77: 559–566.

  • 29

    Kloiber S, Kohli MA, Brueckl T, et al. Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Mol Psychiatry 2010; 15: 736–747.

  • 30

    Nagy G, Ronai Z, Somogyi A, et al. P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1884–1888.

  • 31

    Agardh E, Allebeck P, Hallqvist J, et al. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011; 40: 804–818.

  • 32

    Freeman A, Tyrovolas S, Koyanagi A, et al. The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe). BMC Public Health 2016; 16: 1098.

  • 33

    Berk M, Sarris J, Coulson CE, et al. Lifestyle management of unipolar depression. Acta Psychiatr Scand. 2013; 127(Suppl 443): 38–54.

  • 34

    van Dam RM. The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol. 2003; 18: 1115–1125.

  • 35

    Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am. 1998; 21: 293–307.

  • 36

    Chrousos GP. The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord. 2000; 24(Suppl 2): S50–S55.

  • 37

    Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017; 1391: 20–34.

  • 38

    Kopczak A, Stalla GK, Uhr M. IGF-I in major depression and antidepressant treatment response. Eur Neuropsychopharmacol. 2015; 25: 864–872.

  • 39

    Friedrich N, Thuesen B, Jørgensen T, et al. The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes Care 2012; 35: 768–773.

  • 40

    Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241–1248.

  • 41

    Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine 2016; 86: 100–109.

  • 42

    Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–457.

  • 43

    Laake JP, Stahl D, Amiel SA, et al. The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care 2014; 37: 2186–2192.

  • 44

    Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000; 61(Suppl 11): 37–41.

  • 45

    Kivimäki M, Hamer M, Batty GD, et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care 2010; 33: 2611–2616.

  • 46

    Deuschle M. Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 2013; 26: 60–65.

  • 47

    Andersohn F, Schade R, Suissa S, et al. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009; 166: 591–598.

  • 48

    Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998; 129: 613–621.

  • 49

    Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 2014; 37: 625–633. Erratum Diabetes Care 2016; 39: 1065.

  • 50

    Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000; 160: 3278–3285.

  • 51

    Kivimäki M, Batty GD, Jokela M, et al. Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association? Biol Psychiatry 2011; 70: 978–984.

  • 52

    Deschênes SS, Burns RJ, Pouwer F, et al. Diabetes complications and depressive symptoms: prospective results from the Montreal Diabetes Health and Well-Being Study. Psychosom Med. 2017; 79: 603–612.

  • 53

    Bartoli F, Carrà G, Crocamo C, et al. Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis. Int J Geriatr Psychiatry 2016; 31: 829–836.

  • 54

    Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2010; 33: 264–269.

  • 55

    Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: a meta-analysis and systematic review. Gen Hosp Psychiatry 2013; 35: 217–225.

  • 56

    Gold SM, Dziobek I, Sweat V, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007; 50: 711–719.

  • 57

    Moulton CD, Costafreda SG, Horton P, et al. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav. 2015; 9: 651–662.

  • 58

    Cole J, Costafreda SG, McGuffin P, et al. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J Affect Disord. 2011; 134: 483–487.

  • 59

    Rihmer Z, Blazsek P, Hargittay Cs, et al. Depression, anxiety and suicidal behavior. Recognition and care. [Depresszió, szorongás és az öngyilkos magatartás. Felismerés és ellátás.] Lege Artis Med. 2018; 28: 287–292. [Hungarian]

  • 60

    Tabák AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279–2290.

  • 61

    Herder C, Kowall B, Tabák AG, et al. The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia 2014; 57: 16–29.

  • 62

    Torzsa P, Oláh I, Hargittay Cs, et al. Type 2 diabetes: what is the role of a general practitioner in the treatment of diabetes? [2-es típusú cukorbetegség: milyen szerepe van a családorvosnak a betegség kezelésében?] Lege Artis Med. 2018; 28: 533–540. [Hungarian]

The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.

Mendeley citation style is available HERE.

 

MANUSCRIPT SUBMISSION

  • Impact Factor (2018): 0.564
  • Medicine (miscellaneous) SJR Quartile Score (2018): Q3
  • Scimago Journal Rank (2018): 0.193
  • SJR Hirsch-Index (2018): 18

Language: Hungarian

Founded in 1857
Publication: Weekly, one volume of 52 issues annually

Senior editors

Editor(s)-in-Chief: Papp Zoltán

Read the professional career of Papp Zoltán HERE.

 

Editorial Board

Click for the Editorial Board

Akadémiai Kiadó
Address: Prielle Kornélia u. 21-35. H-1117 Budapest, Hungary
Phone: (+36 1) 464 8235 ---- Fax: (+36 1) 464 8221
Email: orvosihetilap@akkrt.hu